Relation of Circulating Osteoprotegerin Levels on Admission to Microvascular Obstruction After Primary Percutaneous Coronary Intervention

Osteoprotegerin (OPG), a soluble member of the tumor necrosis factor receptor superfamily, has recently been linked to atherosclerosis and development of postinfarction heart failure. This study was designed to assess the association between admission OPG levels and microvascular obstruction (MVO) i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 2011-03, Vol.107 (6), p.857-862
Hauptverfasser:	Erkol, Ayhan, MD, Pala, Selcuk, MD, Kırma, Cevat, MD, Oduncu, Vecih, MD, Dündar, Cihan, MD, Izgi, Akın, MD, Tigen, Kürsat, MD, Gibson, C. Michael, MD, MS
Format:	Artikel
Sprache:	eng
Schlagworte:	Angioplasty Angioplasty, Balloon, Coronary Biological and medical sciences Biomarkers - blood Cardiology Cardiology. Vascular system Cardiovascular Cardiovascular disease Chi-Square Distribution Coronary Angiography Coronary Circulation Diseases of the cardiovascular system Female Humans Linear Models Male Medical sciences Microcirculation Middle Aged Myocardial Infarction - blood Myocardial Infarction - diagnostic imaging Myocardial Infarction - therapy Osteoprotegerin - blood Peptides Plasma Platelet Aggregation Inhibitors - administration & dosage Prospective Studies Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Regression analysis Statistics, Nonparametric Studies TNF inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Osteoprotegerin (OPG), a soluble member of the tumor necrosis factor receptor superfamily, has recently been linked to atherosclerosis and development of postinfarction heart failure. This study was designed to assess the association between admission OPG levels and microvascular obstruction (MVO) in patients who underwent primary percutaneous coronary intervention (p-PCI). Plasma samples for OPG analysis were obtained
ISSN:	0002-9149 1879-1913
DOI:	10.1016/j.amjcard.2010.10.071